American Association for Cancer Research

SHERPA: Unknown

People

  1. Hudis
    Hudis
  2. Solit
    Solit
  3. Rosen
    Rosen
  4. Norton
    Norton
  5. Reis-Filho
    Reis-Filho
  6. Ladanyi
    Ladanyi
  7. Berger
    Berger
  8. Chandarlapaty
    Chandarlapaty
  9. Weigelt
    Weigelt
  10. Wolchok
    Wolchok

Groups

  1. Department of Medicine (1157)
  2. GSK Faculty (950)
  3. Solid Tumor Oncology Division (941)
  4. Sloan Kettering Institute Faculty (580)
  5. Sloan Kettering Institute Postdocs (484)
  6. Breast Medicine Service (458)
  7. Human Oncology and Pathogenesis Program (452)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (355)
  9. Surgery (353)
  10. Molecular Pharmacology and Chemistry Program Faculty (332)
Search Within
Formats
  1. Meeting Abstract (1693)
  2. Journal Article (817)
  3. Conference Paper (10)
  4. Editorial (7)
  5. Review (3)
  6. Miscellaneous (2)
Groups
  1. Department of Medicine (1157)
  2. GSK Faculty (950)
  3. Solid Tumor Oncology Division (941)
  4. Sloan Kettering Institute Faculty (580)
  5. Sloan Kettering Institute Postdocs (484)
  6. Breast Medicine Service (458)

More Groups

People
  1. Clifford Hudis (103)
  2. Jose Baselga (100)
  3. David Solit (95)
  4. Neal Rosen (94)
  5. Larry Norton (74)
  6. Jorge Reis-Filho (73)

More People

Years
  1. 2023 (3)
  2. 2022 (110)
  3. 2021 (145)
  4. 2020 (185)
  5. 2019 (192)
  6. 2018 (180)

More Years

Publications
  1. Cancer Research (2532)

Results (2532)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at Single-Cell Resolution
    Journal Article

    Pine, A. R.; Cirigliano, S. M.; Singhania, R.; Nicholson, J.; da Silva, B.; Leslie, C. S.; Fine, H. A.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell-Derived Cytokines
    Journal Article

    Schwörer, S.; Cimino, F. V.; Ros, M.; Tsanov, K. M.; Ng, C.; Lowe, S. W.; Carmona-Fontaine, C.; Thompson, C. B.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer
    Journal Article

    Qiu, H.; Makarov, V.; Bolzenius, J. K.; Halstead, A.; Parker, Y.; Wang, A.; Iyer, G. V.; Wise, H.; Kim, D.; Thayaparan, V.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Integrative genomics of checkpoint blockade response in advanced non-small cell lung cancer
    Meeting Abstract

    Ravi, A.; Gainor, J.; Arniella, M.; Stewart, C.; Freeman, S.; Awad, M. M.; Forde, P.; Anagnostou, V.; Henick, B.; Riess, J. W.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Associations of inflammatory biomarkers with survival among patients with stage III colon cancer (CALGB/SWOG 80702 [Alliance])
    Meeting Abstract

    Cheng, E.; Qian, S.; Shields, A. F.; Cespedes Feliciano, E. M.; Nixon, A. B.; Shergill, A. P.; Guthrie, K. A.; Couture, F.; Kuebler, P.; Kumar, P.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Ceralasertib and olaparib in the treatment of homologous recombination repair (HRR)-deficient platinum-sensitive ovarian cancer after progression on PARP inhibitors
    Meeting Abstract

    Shapiro, G. I.; Basu, B.; El-Khoueiry, A.; Postel-Vinay, S.; Im, S. A.; Rha, S. Y.; Friedman, C. F.; Italiano, A.; Kim, Y. M.; Lim, M. C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100
    Meeting Abstract

    Dy, G. K.; Govindan, R.; Velcheti, V.; Falchook, G. S.; Italiano, A.; Wolf, J.; Sacher, A. G.; Takahashi, T.; Ramalingam, S. S.; Dooms, C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Exploring the impact of infertility and its treatments on risk of ovarian cancer
    Meeting Abstract

    Lee, A. W.; Phung, M. T.; Jensen, A.; Wu, A. H.; Cramer, D. W.; Modugno, F.; Harris, H.; Doherty, J. A.; Schildkraut, J.; Terry, K. L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Amcenestrant, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/HER2-advanced breast cancer (aBC): Combined biomarker analyses from a phase 1/2 study in postmenopausal women and a phase 1 study in postmenopausal Japanese women
    Meeting Abstract

    Iwata, H.; Bardia, A.; Lord, S.; Linden, H. M.; Campone, M.; Tamura, K.; Yonemori, K.; Mukohara, T.; Combeau, C.; Ternes, N.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer
    Meeting Abstract

    Naing, A.; Callahan, M.; Costello, B. A.; Curti, B.; Hall, E.; Hansen, A.; Long, G. V.; Joshua, A. M.; Wetmore, C.; Weickhardt, A.
    Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: